Pages that link to "Q37445826"
Jump to navigation
Jump to search
The following pages link to Cyclin-dependent kinases as a therapeutic target for stroke. (Q37445826):
Displaying 50 items.
- Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4 (Q24537780) (← links)
- Activation of Transcription Factors AP-1 and NF-κB in Murine Chagasic Myocarditis (Q24682637) (← links)
- Cell cycle activity of neural precursors in the diseased mammalian brain (Q27011457) (← links)
- Neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction AF4 in a mouse model of hypoxic-ischemic brain injury (Q27331512) (← links)
- Bir1 deletion causes malfunction of the spindle assembly checkpoint and apoptosis in yeast (Q27931959) (← links)
- Neuroprotective Mechanisms Mediated by CDK5 Inhibition (Q28082792) (← links)
- cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro (Q28216506) (← links)
- The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1 (Q28258178) (← links)
- Mitochondrial fragmentation in neurodegeneration (Q28284588) (← links)
- Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models (Q28475093) (← links)
- Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A (Q28483833) (← links)
- Regulation of neuron survival and death by p130 and associated chromatin modifiers (Q28567953) (← links)
- Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons (Q28568449) (← links)
- Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat (Q28583944) (← links)
- Regulation of ischemic neuronal death by E2F4-p130 protein complexes (Q28771402) (← links)
- CR8, a selective and potent CDK inhibitor, provides neuroprotection in experimental traumatic brain injury. (Q30513085) (← links)
- Aggravation of brain injury after transient focal ischemia in p53-deficient mice (Q30663515) (← links)
- Mining DNA microarray data using a novel approach based on graph theory (Q30666895) (← links)
- The expression of cyclins in neurons of rats after focal cerebral ischemia (Q33320019) (← links)
- Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis (Q33784450) (← links)
- Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury (Q33852129) (← links)
- A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia-reperfusion injury in mice (Q33854008) (← links)
- c-Jun mediates axotomy-induced dopamine neuron death in vivo (Q33949411) (← links)
- Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. (Q34047944) (← links)
- Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies (Q34147023) (← links)
- The harlequin mouse mutation downregulates apoptosis-inducing factor (Q34152182) (← links)
- NGF deprivation-induced gene expression: after ten years, where do we stand? (Q34286977) (← links)
- Selective CDK inhibitors: promising candidates for future clinical traumatic brain injury trials (Q34412771) (← links)
- Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cells (Q34427924) (← links)
- Complement: a novel factor in basal and ischemia-induced neurogenesis (Q34500822) (← links)
- Cell cycle molecules define a pathway required for neuron death in development and disease (Q34602967) (← links)
- Cyclin-dependent kinases as potential targets to improve stroke outcome. (Q34792871) (← links)
- Mechanistic Insight into DNA Damage and Repair in Ischemic Stroke: Exploiting the Base Excision Repair Pathway as a Model of Neuroprotection (Q34805983) (← links)
- Pharmacological inhibitors of cyclin-dependent kinases (Q34866778) (← links)
- Cell cycle activation and spinal cord injury (Q35006482) (← links)
- Cycling at the interface between neurodevelopment and neurodegeneration (Q35023927) (← links)
- Oxidative stress, cell cycle, and neurodegeneration (Q35086148) (← links)
- Apoptosis and brain ischaemia (Q35092250) (← links)
- Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice (Q35103069) (← links)
- Neuronal cell cycle: the neuron itself and its circumstances (Q35565056) (← links)
- Cell cycle molecules and vertebrate neuron death: E2F at the hub. (Q35597038) (← links)
- Remote Ischemic Conditioning Alters Methylation and Expression of Cell Cycle Genes in Aneurysmal Subarachnoid Hemorrhage. (Q35998441) (← links)
- Transcriptional upregulation of p57 (Kip2) by the cyclin-dependent kinase inhibitor BMS-387032 is E2F dependent and serves as a negative feedback loop limiting cytotoxicity (Q36247797) (← links)
- Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma (Q36324624) (← links)
- Retinal degeneration depends on Bmi1 function and reactivation of cell cycle proteins (Q36616998) (← links)
- Identification of Sleep-Modulated Pathways Involved in Neuroprotection from Stroke (Q36744095) (← links)
- Cyclin-dependent kinases: molecular switches controlling anergy and potential therapeutic targets for tolerance (Q36769222) (← links)
- Role of cell cycle proteins in CNS injury (Q36778834) (← links)
- Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury (Q36781175) (← links)
- Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases (Q36827351) (← links)